Medical Database

Glucagon testing measures the concentration of glucagon, a hormone produced primarily by pancreatic alpha cells that plays a critical role in maintaining blood glucose levels. Glucagon stimulates the liver to convert glycogen into glucose and promotes gluconeogenesis, thereby increasing blood glucose during fasting or hypoglycemia. Measurement of plasma glucagon may be useful in the evaluation of unexplained hypoglycemia, suspected glucagon-secreting pancreatic tumors (glucagonoma), and disorders involving abnormal pancreatic endocrine function. Testing may also support the assessment of conditions associated with impaired glucose regulation and help characterize abnormalities in counter-regulatory hormone responses.

The Interferon-Gamma (IFN-γ) Release Assay (IGRA) is an immunological blood test used primarily to detect latent or active Mycobacterium tuberculosis infection. The assay measures the amount of interferon-gamma released by sensitized T lymphocytes after exposure to tuberculosis-specific antigens such as ESAT-6 and CFP-10. Unlike the tuberculin skin test, IGRA is not affected by prior Bacille Calmette-Guérin (BCG) vaccination and has higher specificity in vaccinated individuals. Commonly used assays include the QuantiFERON-TB Gold Plus and T-SPOT.TB. Results aid clinicians in identifying tuberculosis infection, especially in high-risk populations, immunocompromised patients, healthcare workers, and individuals undergoing screening before immunosuppressive therapy or organ transplantation.

Conversations around innovation, laboratory efficiency, and evidence-based decision support! Medical Database helps laboratories and healthcare organizations streamline medical necessity validation, reimbursement workflows, and compliance through intelligent clinical decision support.
Booth #3522
Anaheim Convention Center

The team is having a blast at ADLM!
Great conversations are happening at Booth 3522. Make sure to visit us and learn more about the right solution for medical necessity and reimbursement.
Anaheim Convention Center

Attending ?
Please stop by our booth 3422 to learn the right solution for medical necessity and reimbursement.
Convention Center

Urine microalbumin testing measures small amounts of albumin in the urine that are not detectable by routine urine dipstick tests. It is an important screening tool for the early detection of kidney damage, particularly in individuals with diabetes, hypertension, or other conditions affecting renal function. Increased urinary albumin excretion, known as microalbuminuria, often represents the earliest clinical sign of diabetic nephropathy and may also indicate an elevated risk of cardiovascular disease. Testing can be performed using a spot urine sample, preferably reported as the urine albumin-to-creatinine ratio (UACR), or through timed urine collections. Early identification of microalbuminuria enables timely interventions, including improved blood pressure and glucose control, to slow kidney disease progression and reduce complications.

TYMS (Thymidylate Synthetase) Gene Mutation Analysis is a molecular test that evaluates genetic alterations affecting the TYMS gene, which encodes thymidylate synthase, an essential enzyme involved in the synthesis of thymidine nucleotides required for DNA replication and repair. Variations in TYMS, including promoter polymorphisms, copy number changes, and other genetic alterations, can influence enzyme expression and activity. This analysis is primarily used in pharmacogenomic assessment, particularly for predicting response and toxicity to fluoropyrimidine-based chemotherapies such as 5-fluorouracil (5-FU) and capecitabine. Altered TYMS activity may contribute to differences in treatment efficacy and adverse effects. Learn more about the testing with Medical Database.
https://app.medicaldatabase.com/site/medical-tests/5edd99d8-825e-4caa-a297-c232fdc446f9

Maple Syrup Urine Disease (MSUD) Testing is performed to detect or confirm a rare inherited metabolic disorder caused by deficiency of the branched-chain alpha-ketoacid dehydrogenase complex. This enzyme defect prevents the proper breakdown of the amino acids leucine, isoleucine, and valine, leading to toxic accumulation in the blood and urine. MSUD testing typically measures branched-chain amino acids using tandem mass spectrometry, while confirmatory testing may include urine organic acid analysis and molecular genetic testing. Early diagnosis is essential because untreated MSUD can cause poor feeding, vomiting, lethargy, developmental delays, seizures, and life-threatening neurological complications. The test plays a vital role in newborn screening, diagnosis, treatment monitoring, and long-term management. Learn more about the testing with Medical Database.
https://app.medicaldatabase.com/site/medical-tests/by-alpha